Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00403247 · ClinicalTrials.gov registry record · NA
Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia
A NA study, sponsored by Nathan Kline Institute for Psychiatric Research.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00403247 is a NA study that has completed, run by Nathan Kline Institute for Psychiatric Research. The registered enrollment target is 50 participants.
The verdict
NCT00403247, a NA study, has completed, sponsored by Nathan Kline Institute for Psychiatric Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether individuals with schizophrenia who will take a high dose of the B-vitamins folate, B12 and pyridoxine, may experience improvement in their symptoms.
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT Capsule with folate, Vitamin B12 & pyridoxine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2004-07 |
| Est. Completion | 2007-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00403247
The ClinicalTrials.gov registry entry for NCT00403247 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nathan Kline Institute for Psychiatric Research, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00403247 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00403247 about?
NCT00403247 is a clinical study titled "Effect of High-Dose B-Complex Vitamins on the Symptoms of Schizophrenia". The purpose of this study is to determine whether individuals with schizophrenia who will take a high dose of the B-vitamins folate, B12 and pyridoxine, may experience improvement in their symptoms.
What is the current status of trial NCT00403247?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2004-07. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00403247?
The interventions under investigation include: placebo (OTHER), Capsule with folate, Vitamin B12 & pyridoxine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00403247?
This trial is sponsored by Nathan Kline Institute for Psychiatric Research, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.